Pasithea therapeutics announces closing of $5 million public offering

Pasithea therapeutics (nasdaq: ktta) closes $5m public offering, adds $1.3m via warrant exercises, funding r&d for pas-004 and other biotech innovations.
KTTA Ratings Summary
KTTA Quant Ranking